Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | MRK | PFE | ||
| Company | Novo Nordisk A/S ADR | Merck & Company | Pfizer Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 48.72 | 121.40 | 27.37 | ||
| High | 48.77 | 122.60 | 27.40 | ||
| Low | 48.18 | 120.50 | 26.58 | ||
| Latest | 48.45 | 121.86 | 26.86 | ||
| Change | -0.78 | +0.20 | -0.51 | ||
| % Change | -1.58% | +0.16% | -1.86% | ||
| Volume | 8,281,643 | 8,932,980 | 40,310,955 | ||
| 20-Day Average Volume | 23,013,711 | 13,485,175 | 51,572,625 | ||
| Previous Close | 49.23 | 121.66 | 27.37 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.53 | 115.36 | 26.72 | ||
| 20-Day Raw Stochastic | 24.90% | 91.50% | 59.70% | ||
| 20-Day Relative Strength | 42.02 | 68.80 | 54.34 | ||
| Weighted Alpha | -32.46 | +51.62 | +7.08 | ||
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.59% since 02/11/26 | +2.14% since 02/11/26 | -3.14% since 02/11/26 | ||
| Low | 48.12 on 02/12/26 | 118.12 on 02/12/26 | 26.58 on 02/19/26 | ||
| High | 50.07 on 02/12/26 | 123.33 on 02/13/26 | 27.94 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -22.27% since 01/16/26 | +11.97% since 01/16/26 | +4.72% since 01/16/26 | ||
| Low | 43.24 on 02/05/26 | 106.03 on 01/28/26 | 25.09 on 01/20/26 | ||
| High | 64.16 on 01/23/26 | 123.33 on 02/13/26 | 27.94 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | -1.12% since 11/19/25 | +28.21% since 11/19/25 | +7.96% since 11/19/25 | ||
| Low | 43.08 on 11/24/25 | 93.90 on 11/20/25 | 24.28 on 11/20/25 | ||
| High | 64.16 on 01/23/26 | 123.33 on 02/13/26 | 27.94 on 02/13/26 | ||
| 6-Month | |||||
| %Chg | -11.56% since 08/19/25 | +43.48% since 08/19/25 | +6.08% since 08/19/25 | ||
| Low | 43.08 on 11/24/25 | 77.58 on 09/25/25 | 23.58 on 09/25/25 | ||
| High | 64.16 on 01/23/26 | 123.33 on 02/13/26 | 27.94 on 02/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 219,811,936 | 301,962,912 | 155,617,824 | ||
| Shares Outstanding, K | 4,465,000 | 2,482,023 | 5,685,708 | ||
| Annual Sales | 46,792,290,000 | 65,011,000,000 | 62,579,000,000 | ||
| Annual Net Income | 15,508,510,000 | 18,254,000,000 | 7,771,000,000 | ||
| Last Quarter Sales | 12,343,020,000 | 16,400,000,000 | 17,557,000,000 | ||
| Last Quarter Net Income | 4,247,770,000 | 2,963,000,000 | -1,648,000,000 | ||
| 60-Month Beta | 0.67 | 0.28 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.02 on 11/05/25 | 2.04 on 02/03/26 | 0.66 on 02/03/26 | ||
| Latest Earnings Date | 05/06/26 | 04/23/26 | 05/05/26 | ||
| Most Recent Dividend | 0.412 on 08/18/25 | 0.850 on 12/15/25 | 0.430 on 01/23/26 | ||
| Next Ex-Dividends Date | 03/30/26 | 03/16/26 | 01/23/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 12.63 | 13.55 | 8.47 | ||